Medios AG - Asset Resilience Ratio

Latest as of December 2025: 9.16%

Medios AG (ILM1) has an Asset Resilience Ratio of 9.16% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Medios AG to assess the company's strategic physical and investment asset allocation.

Liquid Assets

€82.73 Million
≈ $96.72 Million USD Cash + Short-term Investments

Total Assets

€903.04 Million
≈ $1.06 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Medios AG's Asset Resilience Ratio has changed over time. See Medios AG balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Medios AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Medios AG (ILM1) total market value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €81.84 Million 9.06%
Short-term Investments €884.00K 0.1%
Total Liquid Assets €82.73 Million 9.16%

Asset Resilience Insights

  • Limited Liquidity: Medios AG maintains only 9.16% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Medios AG Industry Peers by Asset Resilience Ratio

Compare Medios AG's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Sigma Healthcare Ltd
AU:SIG
Medical Distribution 0.03%
Jointown Pharmaceutical Group Co Ltd
SHG:600998
Medical Distribution 0.08%
Arjo AB (publ)
ST:ARJO-B
Medical Distribution 0.18%
Ebos Group Ltd
AU:EBO
Medical Distribution 0.00%
Paragon Care Ltd
AU:PGC
Medical Distribution 0.00%
Mayne Pharma Group Ltd
AU:MYX
Medical Distribution 4.00%
Cyclopharm Ltd
AU:CYC
Medical Distribution 1.98%
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Medical Distribution 4.48%

Annual Asset Resilience Ratio for Medios AG (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Medios AG.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.10% €883.00K
≈ $1.03 Million
€903.04 Million
≈ $1.06 Billion
+0.01pp
2022-12-31 0.09% €523.00K
≈ $611.44K
€575.96 Million
≈ $673.36 Million
-0.02pp
2021-12-31 0.11% €576.00K
≈ $673.40K
€524.14 Million
≈ $612.78 Million
-0.15pp
2020-12-31 0.26% €515.00K
≈ $602.09K
€194.54 Million
≈ $227.43 Million
+0.05pp
2019-12-31 0.21% €247.64K
≈ $289.52K
€116.57 Million
≈ $136.28 Million
-11.83pp
2018-12-31 12.04% €11.85 Million
≈ $13.85 Million
€98.42 Million
≈ $115.06 Million
-6.34pp
2017-12-31 18.38% €11.34 Million
≈ $13.26 Million
€61.71 Million
≈ $72.14 Million
-17.33pp
2016-12-31 35.71% €17.09 Million
≈ $19.98 Million
€47.86 Million
≈ $55.95 Million
--
pp = percentage points

About Medios AG

XETRA:ILM1 Germany Medical Distribution
Market Cap
$376.91 Million
€322.39 Million EUR
Market Cap Rank
#14737 Global
#1458 in Germany
Share Price
€12.64
Change (1 day)
+1.28%
52-Week Range
€11.28 - €17.32
All Time High
€40.95
About

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and p… Read more